Volume 3
Current Research: Integrative Medicine
Chronic Diseases 2018
July 16-17, 2018
Page 14
Chronic Diseases
July 16-17, 2018 Berlin, Germany
2
nd
International Conference on
Shen-Yuan Yuan, Curr Res Integr Med 2018, Volume 3
DOI: 10.4172/2529-797X-C1-001
A48-month prospective study of the effects of multifactorial interventions on cardiovascular risk factors
in patients with T2DM in an urban community: The Beijing communities diabetes study 12
T
o assess whether multifactorial interventions have long-term effects on the risk of diabetes-related macro-vascular
complications in patients with type-2 diabetes mellitus living in urban communities of Beijing. A total of 2926 patients with
type-2 diabetes from 15 community health centers were divided into a Diabetes Mellitus (DM) group (n=824), a Hypertension
(HTN) group (n=1267) and a Cardiovascular Disease (CVD) group (n=835). By applying Framingham Risk Scores (FRS),
patients in the 3 groups were subdivided into low (FRS <10%), medium (FRS 10%-20%) and high (FRS >20%) Framingham
risk strata. After 48 months, patients were followed-up to assess the long-term effects of the multifactorial interventions. At
baseline, the patients’ mean Neck Circumference (NC) was significantly higher in the HTN and CVD groups than in the
DM group (P<0.05). After 48 months of follow-up, the CVD and HTN groups both had higher blood pressures and lipid
levels than the DM group (both P<0.01). Although there was no significant change in the FRS versus baseline in the low
and medium Framingham risk strata, a significant reduction in FRS was noted in the high Framingham risk strata. In Cox
multivariate analyses, the HTN and CVD groups had higher incidences of endpoint events than the DM group. This study has
demonstrated for the first time a relationship between NC and CVD in diabetic patients. Multifactorial interventions for CVD
risk factors over 48 months lowered the estimated 10-year risk for CVD events in diabetes. FRS score influences the incidence
of CVD events in diabetic patients. Aggressive risk reduction should be focused on these individuals who had high FRS score.
Biography
Shen-Yuan Yuan is the Professor and Chief Physician of Internal Medicine, Beijing Tongren Hospital, Capital Medical University, China. He has served as the Director of
Internal Medicine, Director of Digestive Science and Director of Endocrinology in Beijing Tongren Hospital. He has won 21 awards, including the first Prize, the second prize
and the third prize of Beijing Municipal Science and Technology Progress. Currently he is the Principal Leader of Beijing Community Diabetes Study (BCDS, 2008-2018)
and the BRIDGES project from the International Diabetes Federation.
fulvic@126.comShen-Yuan Yuan
Beijing Tongren Hospital-Capital Medical University, China